Trial intelligence / Profile preview

Melatonin intervention and chronobiological signatures in children and adolescents with autism spectrum disorder

RBR-6vnpb2sRecruiting

Sponsor
Universidade Estadual Paulista
Start
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of melatonin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Universidade Estadual Paulista. Primary endpoints: Chronobiological parameters, Sleep parameters by actigraphy and diary and 1 more. Started Mar 2026; status: recruiting.

02

Drugs

melatonin
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on RBR-6vnpb2s.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6vnpb2s.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call